Home › Employers › University of Minnesota Physicians › Hematologist/Oncologist
Hematologist/Oncologist at University of Minnesota Physicians: H-1B salaries
9 labor condition applications for the job title Hematologist/Oncologist at University of Minnesota Physicians. Median offered base salary $162,802; middle half $80,746–$163,539.
Applications (LCAs)9
Median offered salary$162,802
Middle half of salaries$80,746–$163,539
10th–90th percentile$66,705–$263,178
By fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 2 | $131,807 |
| FY2025 | 2 | $341,024 |
| FY2026 | 5 | $162,802 |
Applications
| Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|
| $162,802–$197,900 Level III | Minneapolis, MN | May 7, 2026 | Aug 31, 2026 | Certified |
| $80,746–$199,500 Level II | Minneapolis, MN | Mar 27, 2026 | Jul 20, 2026 | Certified |
| $163,539 Level I | Minneapolis, MN | Mar 25, 2026 | Jun 30, 2026 | Certified |
| $163,539 Level I | Minneapolis, MN | Mar 18, 2026 | Jun 30, 2026 | Certified |
| $64,958–$199,500 Level I | Minneapolis, MN | Feb 23, 2026 | Jun 29, 2026 | Certified |
| $152,048–$195,000 Level II | Minneapolis, MN | Apr 16, 2025 | Jun 1, 2025 | Certified |
| $67,142–$227,900 Level II | Minneapolis, MN | Aug 11, 2023 | Aug 31, 2023 | Certified |
| $196,472 Level II | Minneapolis, MN | Jun 8, 2023 | Jul 1, 2023 | Certified |
| $530,000 Level II | Wyoming, MN | Dec 6, 2021 | Mar 14, 2022 | Certified, then withdrawn |
Hematologist/Oncologist at all employers →
Other jobs at University of Minnesota Physicians
- Neurologist$81,422
- Anesthesiologist$76,502
- Nephrologist$66,539
- Pulmonary and Critical Care Physician$172,224
- Oncologist$101,358
- Physician$86,382
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).